Xochelli, A, Baliakas, P, Kavakiotis, I, Agathangelidis, A, Sutton, LA, Minga, E, Ntoufa, S, Tausch, E, Yan, XJ, Shanafelt, T, Plevova, K, Boudjogra, M, Rossi, D, Davis, Z, Navarro, A, Sandberg, Y, Vojdeman, FJ, Scarfo, L, Stavroyianni, N, Sudarikov, A, Veronese, S, Tzenou, T, Karan-Djurasevic, T, Catherwood, M, Kienle, D, Chatzouli, M, Facco, M, Bahlo, J, Pott, C, Pedersen, LB, Mansouri, L, Smedby, KE, Chu, CC, Giudicelli, V, Lefranc, MP, Panagiotidis, P, Juliusson, G, Anagnostopoulos, A, Vlahavas, I, Antic, D, Trentin, L, Montillo, M, Niemann, C, Dohner, H
, Langerak, T, Pospisilova, S, Hallek, M, Campo, E, Chiorazzi, N, Maglaveras, N, Oscier, D, Gaidano, G, Jelinek, DF, Stilgenbauer, S, Chouvarda, I, Darzentas, N, Belessi, C, Davi, F, Hadzidimitriou, A, Rosenquist, R, Ghia, P & Stamatopoulos, K 2017, '
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes',
Clinical Cancer Research, vol. 23, no. 17, pp. 5292-5301.
https://doi.org/10.1158/1078-0432.ccr-16-3100